EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS62 - Asthma 7

Sunday 02 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
Asthma in the Intermediate/Intensive Care of a Central Hospital
Benralizumab for the treatment of severe asthma
Characteristics of asthma phenotypes: Does coexistence of allergic and eosinophilic asthma increase asthma severity?
Comparative effectiveness of biologic therapies for patients with asthma: A nationwide population-based cohort study
Correlation between Fractional exhaled nitric oxide and pulmonary function test in children with asthma
Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions
Genetic polymorphisms associated with the development of asthma in the Kazakh population
Impact of obesity on the control of occupational asthma
Is Chronic Rhinosinusitis still an underestimated disease
Metal asthma: A case report of 4 patients
The Bacterial Lysate 0M-85BV reduces risk for exacerbations and oral corticosteroids in allergic asthma: A retrospective parallel group-controlled study
The significance of FeNO test in patients with different asthma endotypes
Tumor necrosis factor-alpha in allergic inflammation in overweight children with asthma
Vitamin D3 deficiency is more common in children with asthma than in children with other allergic diseases

Chairs

Speakers